A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

Pfizer has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that gets the New York drugmaker ...

Swiss drugmaker Roche signalled its ambition to join Eli Lilly and Novo Nordisk at the top of the booming weight-loss market ...

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...

Roche Holding AG will move an experimental obesity shot into late-stage trials next year in a bid to challenge leaders in the ...

By Andrew Silver SHANGHAI (Reuters) -Innovent Biologics' newly launched weight-loss drug is making inroads in its home market ...

An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

The drug. orforglipron, works on the same receptor as semaglutide (Ozempic/Wegovy), but can be taken without restrictions on ...

The medication could help people lose weight while eating the same amount in a bid to help treat the underlying causes of ...

GLP-1 drugs are reshaping our bodies, but also our society. They may even help to treat major diseases once thought incurable.